NFKB1 and viral infectious disease: In order to test which cellular signaling pathway(s) might be involved in the activation of NF-κB in response to vMyxM013-KO virus infection, we used the kinase inhibitors U0126, an ERK1/2 inhibitor and LY294002, a PI3 kinase inhibitor.